Jump Financial, LLC Theravance Biopharma, Inc. Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$8.22 - $11.59 $357,134 - $503,550	43,447 New	43,447 $389,000
Q2 2023 Oct 21, 2024	BUY	$10.16 - $11.92 $106,009 - $124,373	10,434 New	10,434 $107,000
Q2 2023 Aug 07, 2023	BUY	$10.16 - $11.92 $106,009 - $124,373	10,434 New	10,434 $107,000
Q4 2022 Feb 13, 2023	SELL	$9.65 - $11.34 $79,130 - $92,988	-8,200 Reduced 14.14%	49,800 $558,000
Q3 2022 Nov 07, 2022	BUY	$8.39 - $10.22 $486,620 - $592,760	58,000 New	58,000 $588,000
Q1 2022 May 12, 2022	SELL	$8.33 - $12.96 $99,127 - $154,224	-11,900 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$7.42 - $11.05 $88,298 - $131,495	11,900 New	11,900 $131,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.